Serina Therapeutics, Inc. Amortization of Deferred Leasing Fees
Serina Therapeutics, Inc. (SER) reported Amortization of Deferred Leasing Fees of $17.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredLeasingFees · last filed 2019-04-01
- Serina Therapeutics, Inc. amortization of deferred leasing fees for fiscal 2017 was $17.00K.
| Period end | Amortization of Deferred Leasing Fees 12 month |
|---|---|
| 2017-12-31 | $17.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |